Epidemiologic Trends of Thalassemia, 2006-2018: A Nationwide Population-Based Study
DC Field | Value | Language |
---|---|---|
dc.contributor.author | Lee, Jee-Soo | - |
dc.contributor.author | Rhee, Tae-Min | - |
dc.contributor.author | Jeon, Kibum | - |
dc.contributor.author | Cho, Yonggeun | - |
dc.contributor.author | Lee, Seung-Woo | - |
dc.contributor.author | Han, Kyung-Do | - |
dc.contributor.author | Seong, Moon-Woo | - |
dc.contributor.author | Park, Sung-Sup | - |
dc.contributor.author | Lee, Young Kyung | - |
dc.date.accessioned | 2023-03-27T02:40:06Z | - |
dc.date.available | 2023-03-27T02:40:06Z | - |
dc.date.created | 2023-02-27 | - |
dc.date.issued | 2022-05 | - |
dc.identifier.issn | 2077-0383 | - |
dc.identifier.uri | http://scholarworks.bwise.kr/ssu/handle/2018.sw.ssu/43612 | - |
dc.description.abstract | Thalassemia is the most common form of hereditary anemia. Here, we aimed to investigate the 13-year trend of the epidemiologic profiles and risk of comorbidities in thalassemia using a nationwide population-based registry in Korea. Diagnosis of thalassemia, the comorbidities and transfusion events in patients with thalassemia were identified in the Korean National Health Insurance database, which includes the entire population. The prevalence of thalassemia increased from 0.74/100,000 in 2006 to 2.76/100,000 in 2018. Notably, the incidence rate has nearly doubled in the last 2 years from 0.22/100,000 in 2016 to 0.41/100,000 in 2018. The annual transfusion rate gradually decreased from 34.7% in 2006 to 20.6% in 2018. Transfusion events in patients with thalassemia were significantly associated with the risk of comorbidities (diabetes: odds ratio [OR] = 3.68, 95% confidence interval [CI] = 2.59-5.22; hypertension: OR = 3.06, 95% CI = 2.35-4.00; dyslipidemia: OR = 1.72, 95% CI = 1.22-2.43; atrial fibrillation: OR = 3.52, 95% CI = 1.69-7.32; myocardial infarction: OR = 3.02, 95% CI = 1.09-8.38; stroke: OR = 3.32, 95% CI = 2.05-5.36; congestive heart failure: OR = 2.83, 95% CI = 1.62-4.97; end-stage renal disease: OR = 3.25, 95% CI = 1.96-5.37). Early detection of comorbidities and timely intervention are required for the management of thalassemia. | - |
dc.language | 영어 | - |
dc.language.iso | en | - |
dc.publisher | MDPI | - |
dc.relation.isPartOf | JOURNAL OF CLINICAL MEDICINE | - |
dc.title | Epidemiologic Trends of Thalassemia, 2006-2018: A Nationwide Population-Based Study | - |
dc.type | Article | - |
dc.identifier.doi | 10.3390/jcm11092289 | - |
dc.type.rims | ART | - |
dc.identifier.bibliographicCitation | JOURNAL OF CLINICAL MEDICINE, v.11, no.9 | - |
dc.description.journalClass | 1 | - |
dc.identifier.wosid | 000795351300001 | - |
dc.identifier.scopusid | 2-s2.0-85128545059 | - |
dc.citation.number | 9 | - |
dc.citation.title | JOURNAL OF CLINICAL MEDICINE | - |
dc.citation.volume | 11 | - |
dc.contributor.affiliatedAuthor | Lee, Seung-Woo | - |
dc.type.docType | Article | - |
dc.description.isOpenAccess | Y | - |
dc.subject.keywordAuthor | thalassemia | - |
dc.subject.keywordAuthor | prevalence | - |
dc.subject.keywordAuthor | incidence | - |
dc.subject.keywordAuthor | comorbidity | - |
dc.subject.keywordAuthor | nationwide population-based study | - |
dc.subject.keywordPlus | BETA-THALASSEMIA | - |
dc.subject.keywordPlus | COMPLICATIONS | - |
dc.subject.keywordPlus | PREVALENCE | - |
dc.relation.journalResearchArea | General & Internal Medicine | - |
dc.relation.journalWebOfScienceCategory | Medicine, General & Internal | - |
dc.description.journalRegisteredClass | scie | - |
dc.description.journalRegisteredClass | scopus | - |
Items in ScholarWorks are protected by copyright, with all rights reserved, unless otherwise indicated.
Soongsil University Library 369 Sangdo-Ro, Dongjak-Gu, Seoul, Korea (06978)02-820-0733
COPYRIGHT ⓒ SOONGSIL UNIVERSITY, ALL RIGHTS RESERVED.
Certain data included herein are derived from the © Web of Science of Clarivate Analytics. All rights reserved.
You may not copy or re-distribute this material in whole or in part without the prior written consent of Clarivate Analytics.